실시간 PCR(qPCR) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Real Time Pcr Qpcr Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,922,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,109,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,772,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 실시간 PCR(qPCR) 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 촉진요인, 동향, 기회 및 과제를 포함한 주요 시장 역학을 상세히 평가하고 시장 구조에 대한 심층적인 인사이트를 제공합니다.

주요 인사이트

• 실시간 PCR(qPCR) 시장 규모(2024E) : 39억 8,000만 달러
• 예상 시장 규모(2033F) : 78억 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 7.7%

실시간 PCR(qPCR) 시장 - 조사 범위:

실시간 PCR(qPCR) 기술은 유전자 발현 분석, 유전자 돌연변이 조사, 병원체 검출 등 다양한 과학적 응용 분야에서 중요한 역할을 하고 있습니다. 이 기술은 실시간으로 핵산을 정확하고 정량적으로 측정할 수 있으며, 고감도, 특이성, 효율성 등의 이점을 제공합니다. 실시간 PCR(qPCR) 시장은 연구 기관, 진단 실험실, 병원, 생명공학 기업 등을 대상으로 다양한 장비, 시약, 소모품 등을 제공하고 있습니다.

시장 촉진요인:

세계 실시간 PCR(qPCR) 시장은 정확한 진단 도구가 필요한 감염성 및 유전성 질환의 증가와 같은 몇 가지 중요한 요인에 의해 주도되고 있습니다. 개인 맞춤형 의료에 대한 수요 증가와 분자생물학 연구의 발전은 시장 확대를 더욱 촉진할 것입니다. 멀티플렉스 qPCR 분석법 개발 및 열 사이클러의 개선과 같은 기술 혁신은 Real-Time PCR 기술의 기능과 응용을 강화하고 있습니다. 또한, 연구 활동의 확대와 유전체학 및 단백질체학 연구를 위한 자금 조달은 다양한 분야에서 qPCR 기술의 채택을 확대하는 데 기여하고 있습니다.

시장 억제요인:

실시간 PCR(qPCR) 시장은 유망한 성장세에도 불구하고, 첨단 장비 및 시약과 관련된 높은 비용에 대한 도전에 직면해 있습니다. 또한, qPCR 기술의 복잡성과 전문 교육이 필요하다는 점도 특히 개발도상국에서는 도입에 걸림돌이 될 수 있습니다. 또한, 진단 분석법 승인에 대한 엄격한 규제 요건과 지속적인 기기 검증 및 보정의 필요성도 시장 역학에 영향을 미칠 수 있습니다. 이러한 문제를 해결하기 위해서는 지속적인 기술 혁신, 비용 절감 전략, 교육 및 훈련에 대한 지원 강화가 필요합니다.

시장 기회:

실시간 PCR(qPCR) 시장은 기술 발전, 연구 및 진단 애플리케이션의 증가, 의료 수요의 증가로 인해 큰 성장 기회가 있으며, qPCR과 차세대 염기서열 분석(NGS)과 같은 다른 분자 기술과의 통합은 연구 및 임상 진단에 새로운 길을 열어줄 것입니다. 감염병 발생과 암 진단에 대한 관심이 높아짐에 따라 혁신적인 솔루션을 개발하는 시장 플레이어에게 큰 기회가 될 것입니다. 전략적 파트너십, R&D 투자, 비용 효율적인 qPCR 솔루션 도입은 새로운 비즈니스 기회를 활용하고 시장 리더십을 유지하는 데 필수적입니다.

본 보고서에서 다루는 주요 질문들

• 실시간 PCR(qPCR) 시장의 세계 성장을 촉진하는 주요 요인은 무엇인가?
• 연구 및 임상 현장에서 어떤 qPCR 기술 및 응용 분야가 인기를 끌고 있는가?
• 기술의 발전은 실시간 PCR(qPCR) 시장의 경쟁 구도에 어떤 영향을 미치고 있는가?
• 실시간 PCR(qPCR) 시장에 기여하는 주요 플레이어는 누구이며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 실시간 PCR(qPCR) 시장의 새로운 트렌드와 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 핵심성공요인

• 채용률/사용 상황 분석 - 지역별
• 파이프라인 평가
• 규제 시나리오
• 기술 평가
• PESTEL 분석
• Porters 분석
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 제품별
  • 용도별
  • 최종사용자별
  • 지역별
• 2024년 시장 시나리오

제7장 세계 시장 수요(금액) 분석

• 시장(금액) 분석, 2019-2023년
• 시장(금액) 분석과 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대적 수익 기회

제8장 제품별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 실시간 PCR(qPCR) 시스템
  • 시약과 어세이
  • 실시간 PCR(qPCR) 소모품
    • PCR 프라이머, 어세이, 어레이
    • PCR 플레이트, 씰, 튜브
• 제품별 시장 매력 분석

제9장 용도별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 임상
  • 조사
  • 법의학 기타
• 용도별 시장 매력 분석

제10장 최종사용자별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 병원
  • 진단 검사실
  • 학술조사기관
  • 바이오의약품 기업
  • 임상시험수탁기관
  • 동물 건강
  • 식품·농업 산업
• 최종사용자별 시장 매력 분석

제11장 지역별 : 세계 시장 분석

• 소개
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카
• 지역별 시장 매력 분석

제12장 북미 시장 분석

제13장 라틴아메리카 시장 분석

제14장 유럽 시장 분석

제15장 동아시아 시장 분석

제16장 남아시아 시장 분석

제17장 오세아니아 시장

제18장 중동 및 아프리카 시장 분석

제19장 시장 구조 분석

• 기업 계층별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제20장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마크
• 경쟁 상세
  • Medtronic plc
  • St. Jude Medical Inc.
  • Boston Scientific Corporation
  • Abbott
  • Cyberonic, Inc.
  • Qiagen
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • BIOMERIEUX
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation

제21장 사용되는 가정과 두문자어

제22장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Real-Time PCR (qPCR) market. This report provides an in-depth evaluation of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

• Real-Time PCR (qPCR) Market Size (2024E): USD 3.98 Billion
• Projected Market Value (2033F): USD 7.8 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 7.7%

Real-Time PCR (qPCR) Market - Report Scope:

Real-Time PCR (qPCR) technology plays a crucial role in various scientific applications, including gene expression analysis, genetic variation studies, and pathogen detection. This technology enables accurate and quantitative measurement of nucleic acids in real time, offering advantages such as high sensitivity, specificity, and efficiency. The Real-Time PCR (qPCR) market caters to research institutions, diagnostic laboratories, hospitals, and biotechnology companies, providing a range of instruments, reagents, and consumables.

Market Growth Drivers:

The global Real-Time PCR (qPCR) market is driven by several key factors, including the increasing prevalence of infectious diseases and genetic disorders, which necessitate precise diagnostic tools. The growing demand for personalized medicine and advancements in molecular biology research further propel market expansion. Technological innovations, such as the development of multiplex qPCR assays and improvements in thermal cyclers, enhance the capabilities and applications of Real-Time PCR technology. Moreover, the expansion of research activities and funding for genomics and proteomics research contribute to the growing adoption of qPCR technology across various sectors.

Market Restraints:

Despite its promising growth, the Real-Time PCR (qPCR) market faces challenges related to high costs associated with advanced instruments and reagents. The complexity of qPCR technology and the need for specialized training can also pose barriers to adoption, particularly in developing regions. Additionally, the stringent regulatory requirements for the approval of diagnostic assays and the need for continuous validation and calibration of instruments may impact market dynamics. Addressing these challenges requires ongoing innovation, cost reduction strategies, and enhanced support for training and education.

Market Opportunities:

The Real-Time PCR (qPCR) market presents significant growth opportunities driven by advancements in technology, increasing research and diagnostic applications, and expanding healthcare needs. The integration of qPCR with other molecular techniques, such as next-generation sequencing (NGS), offers new avenues for research and clinical diagnostics. The growing focus on infectious disease outbreaks and cancer diagnostics creates substantial opportunities for market players to develop innovative solutions. Strategic partnerships, investments in R&D, and the introduction of cost-effective qPCR solutions are essential to capitalize on emerging opportunities and sustain market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Real-Time PCR (qPCR) market globally?
• Which qPCR technologies and applications are gaining traction in research and clinical settings?
• How are technological advancements influencing the competitive landscape of the Real-Time PCR (qPCR) market?
• Who are the key players contributing to the Real-Time PCR (qPCR) market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global Real-Time PCR (qPCR) market?

Competitive Intelligence and Business Strategy:

Leading players in the global Real-Time PCR (qPCR) market, including Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced qPCR platforms, reagents, and consumables, catering to diverse research and diagnostic needs. Collaborations with academic institutions, research organizations, and healthcare providers facilitate market access and promote technology adoption. Emphasis on product development, regulatory compliance, and customer support drives market growth and enhances competitive positioning in the rapidly evolving Real-Time PCR landscape.

Key Companies Profiled:

• Medtronic plc
• St. Jude Medical Inc.
• Boston Scientific Corporation
• Abbott
• Cyberonic, Inc.
• Qiagen
• Bio-Rad Laboratories Inc.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• GE Healthcare
• BIOMERIEUX
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Fluidigm Corporation

Key Segments Covered in Real time PCR qPCR Industry Research

Product:

• Real-Time PCR (qPCR) Systems
• Reagents and Assays
• Real-Time PCR (qPCR) Consumables

Application:

• Clinical
• Research
• Forensic and Others

End User:

• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes
• Biopharmaceutical Companies
• Contract Research Organizations
• Animal Health
• Food & Agriculture Industries

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmap
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Adoption Rate/Usage Analysis - By Region
• 4.2. Pipeline Assessment
• 4.3. Regulatory Scenario
• 4.4. Technology Assessment
• 4.5. PESTEL Analysis
• 4.6. Porter's Analysis
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Polymerase Chain Reaction Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Prevalence of Chronic and Infectious Diseases
  • 5.2.2. Rising Adoption of Scientific Sciences
  • 5.2.3. Growing Use of PCR Techniques
  • 5.2.4. Expanding Biopharmaceutical and Biotechnology Industries
  • 5.2.5. Increased Disease Diagnosis
  • 5.2.6. Efforts in Discovering Novel Drugs
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Application
  • 6.1.3. By End User
  • 6.1.4. By Region
• 6.2. 2024 Market Scenario

7. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
  • 8.3.1. Real-Time PCR (qPCR) Systems
  • 8.3.2. Reagents and Assays
  • 8.3.3. Real-Time PCR (qPCR) Consumables
    • 8.3.3.1. PCR Primers, Assays, and Arrays
    • 8.3.3.2. PCR Plates, Seals & Tubes
• 8.4. Market Attractiveness Analysis, by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Application, 2024-2033
  • 9.3.1. Clinical
  • 9.3.2. Research
  • 9.3.3. Forensic and Others
• 9.4. Market Attractiveness Analysis, by Application

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
  • 10.3.1. Hospitals
  • 10.3.2. Diagnostic Laboratories
  • 10.3.3. Academic and Research Institutes
  • 10.3.4. Biopharmaceutical Companies
  • 10.3.5. Contract Research Organizations
  • 10.3.6. Animal Health
  • 10.3.7. Food & Agriculture Industries
• 10.4. Market Attractiveness Analysis, by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Region, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product
  • 12.3.3. By Application
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By Application
  • 12.4.4. By End User
• 12.5. Market Trends
• 12.6. Key Market Participants - Intensity Mapping
• 12.7. Drivers and Restraints - Impact Analysis
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. U.S. Market Analysis
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 12.8.1.2.1. By Product
      • 12.8.1.2.2. By Application
      • 12.8.1.2.3. By End User
  • 12.8.2. Canada Market Analysis
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 12.8.2.2.1. By Product
      • 12.8.2.2.2. By Application
      • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. Mexico
    • 13.3.1.2. Brazil
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Product
  • 13.3.3. By Application
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Application
  • 13.4.4. By End User
• 13.5. Market Trends
• 13.6. Key Market Participants - Intensity Mapping
• 13.7. Drivers and Restraints - Impact Analysis
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Mexico Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By Application
      • 13.8.1.2.3. By End User
  • 13.8.2. Brazil Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By Application
      • 13.8.2.2.3. By End User
  • 13.8.3. Argentina Market Analysis
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 13.8.3.2.1. By Product
      • 13.8.3.2.2. By Application
      • 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. BENELUX
    • 14.3.1.7. Russia
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Product
  • 14.3.3. By Application
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Application
  • 14.4.4. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Germany Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Application
      • 14.8.1.2.3. By End User
  • 14.8.2. Italy Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Application
      • 14.8.2.2.3. By End User
  • 14.8.3. France Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By Application
      • 14.8.3.2.3. By End User
  • 14.8.4. U.K. Market Analysis
    • 14.8.4.1. Introduction
    • 14.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.4.2.1. By Product
      • 14.8.4.2.2. By Application
      • 14.8.4.2.3. By End User
  • 14.8.5. Spain Market Analysis
    • 14.8.5.1. Introduction
    • 14.8.5.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.5.2.1. By Product
      • 14.8.5.2.2. By Application
      • 14.8.5.2.3. By End User
  • 14.8.6. BENELUX Market Analysis
    • 14.8.6.1. Introduction
    • 14.8.6.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.6.2.1. By Product
      • 14.8.6.2.2. By Application
      • 14.8.6.2.3. By End User
  • 14.8.7. Russia Market Analysis
    • 14.8.7.1. Introduction
    • 14.8.7.2. Market Analysis and Forecast, by Market Taxonomy
      • 14.8.7.2.1. By Product
      • 14.8.7.2.2. By Application
      • 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. China
    • 15.3.1.2. Japan
    • 15.3.1.3. South Korea
  • 15.3.2. By Product
  • 15.3.3. By Application
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Product
  • 15.4.2. By Application
  • 15.4.3. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. China Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Application
      • 15.8.1.2.3. By End User
  • 15.8.2. Japan Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Application
      • 15.8.2.2.3. By End User
  • 15.8.3. South Korea Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Application
      • 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Indonesia
    • 16.3.1.3. Malaysia
    • 16.3.1.4. Thailand
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product
  • 16.3.3. By Application
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Application
  • 16.4.4. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. India Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Application
      • 16.8.1.2.3. By End User
  • 16.8.2. Indonesia Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Application
      • 16.8.2.2.3. By End User
  • 16.8.3. Malaysia Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Application
      • 16.8.3.2.3. By End User
  • 16.8.4. Thailand Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Application
      • 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Product
  • 17.3.3. By Application
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Application
  • 17.4.4. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. Australia Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Application
      • 17.8.1.2.3. By End User
  • 17.8.2. New Zealand Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Application
      • 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) Trend Analysis, by Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkiye
    • 18.3.1.3. South Africa
    • 18.3.1.4. North Africa
    • 18.3.1.5. Rest of Middle East and Africa
  • 18.3.2. By Product
  • 18.3.3. By Application
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Product
  • 18.4.2. By Application
  • 18.4.3. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. GCC Countries Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Application
      • 18.8.1.2.3. By End User
  • 18.8.2. Turkiye Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Application
      • 18.8.2.2.3. By End User
  • 18.8.3. South Africa Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Application
      • 18.8.3.2.3. By End User
  • 18.8.4. North Africa Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Application
      • 18.8.4.2.3. By End User

19. Market Structure Analysis

• 19.1. Market Analysis, by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Competition Benchmarking
• 20.3. Competition Deep Dive
  • 20.3.1. Medtronic plc
    • 20.3.1.1. Overview
    • 20.3.1.2. Product Portfolio
    • 20.3.1.3. Sales Footprint
    • 20.3.1.4. Key Financials
    • 20.3.1.5. SWOT Analysis
    • 20.3.1.6. Strategy Overview
      • 20.3.1.6.1. Marketing Strategy
      • 20.3.1.6.2. Product Strategy
      • 20.3.1.6.3. Channel Strategy
  • 20.3.2. St. Jude Medical Inc.
    • 20.3.2.1. Overview
    • 20.3.2.2. Product Portfolio
    • 20.3.2.3. Sales Footprint
    • 20.3.2.4. Key Financials
    • 20.3.2.5. SWOT Analysis
    • 20.3.2.6. Strategy Overview
      • 20.3.2.6.1. Marketing Strategy
      • 20.3.2.6.2. Product Strategy
      • 20.3.2.6.3. Channel Strategy
  • 20.3.3. Boston Scientific Corporation
    • 20.3.3.1. Overview
    • 20.3.3.2. Product Portfolio
    • 20.3.3.3. Sales Footprint
    • 20.3.3.4. Key Financials
    • 20.3.3.5. SWOT Analysis
    • 20.3.3.6. Strategy Overview
      • 20.3.3.6.1. Marketing Strategy
      • 20.3.3.6.2. Product Strategy
      • 20.3.3.6.3. Channel Strategy
  • 20.3.4. Abbott
    • 20.3.4.1. Overview
    • 20.3.4.2. Product Portfolio
    • 20.3.4.3. Sales Footprint
    • 20.3.4.4. Key Financials
    • 20.3.4.5. SWOT Analysis
    • 20.3.4.6. Strategy Overview
      • 20.3.4.6.1. Marketing Strategy
      • 20.3.4.6.2. Product Strategy
      • 20.3.4.6.3. Channel Strategy
  • 20.3.5. Cyberonic, Inc.
    • 20.3.5.1. Overview
    • 20.3.5.2. Product Portfolio
    • 20.3.5.3. Sales Footprint
    • 20.3.5.4. Key Financials
    • 20.3.5.5. SWOT Analysis
    • 20.3.5.6. Strategy Overview
      • 20.3.5.6.1. Marketing Strategy
      • 20.3.5.6.2. Product Strategy
      • 20.3.5.6.3. Channel Strategy
  • 20.3.6. Qiagen
    • 20.3.6.1. Overview
    • 20.3.6.2. Product Portfolio
    • 20.3.6.3. Sales Footprint
    • 20.3.6.4. Key Financials
    • 20.3.6.5. SWOT Analysis
    • 20.3.6.6. Strategy Overview
      • 20.3.6.6.1. Marketing Strategy
      • 20.3.6.6.2. Product Strategy
      • 20.3.6.6.3. Channel Strategy
  • 20.3.7. Bio-Rad Laboratories Inc.
    • 20.3.7.1. Overview
    • 20.3.7.2. Product Portfolio
    • 20.3.7.3. Sales Footprint
    • 20.3.7.4. Key Financials
    • 20.3.7.5. SWOT Analysis
    • 20.3.7.6. Strategy Overview
      • 20.3.7.6.1. Marketing Strategy
      • 20.3.7.6.2. Product Strategy
      • 20.3.7.6.3. Channel Strategy
  • 20.3.8. Agilent Technologies, Inc.
    • 20.3.8.1. Overview
    • 20.3.8.2. Product Portfolio
    • 20.3.8.3. Sales Footprint
    • 20.3.8.4. Key Financials
    • 20.3.8.5. SWOT Analysis
    • 20.3.8.6. Strategy Overview
      • 20.3.8.6.1. Marketing Strategy
      • 20.3.8.6.2. Product Strategy
      • 20.3.8.6.3. Channel Strategy
  • 20.3.9. Thermo Fisher Scientific, Inc.
    • 20.3.9.1. Overview
    • 20.3.9.2. Product Portfolio
    • 20.3.9.3. Sales Footprint
    • 20.3.9.4. Key Financials
    • 20.3.9.5. SWOT Analysis
    • 20.3.9.6. Strategy Overview
      • 20.3.9.6.1. Marketing Strategy
      • 20.3.9.6.2. Product Strategy
      • 20.3.9.6.3. Channel Strategy
  • 20.3.10. GE Healthcare
    • 20.3.10.1. Overview
    • 20.3.10.2. Product Portfolio
    • 20.3.10.3. Sales Footprint
    • 20.3.10.4. Key Financials
    • 20.3.10.5. SWOT Analysis
    • 20.3.10.6. Strategy Overview
      • 20.3.10.6.1. Marketing Strategy
      • 20.3.10.6.2. Product Strategy
      • 20.3.10.6.3. Channel Strategy
  • 20.3.11. BIOMERIEUX
    • 20.3.11.1. Overview
    • 20.3.11.2. Product Portfolio
    • 20.3.11.3. Sales Footprint
    • 20.3.11.4. Key Financials
    • 20.3.11.5. SWOT Analysis
    • 20.3.11.6. Strategy Overview
      • 20.3.11.6.1. Marketing Strategy
      • 20.3.11.6.2. Product Strategy
      • 20.3.11.6.3. Channel Strategy
  • 20.3.12. Bio-Rad Laboratories, Inc.
    • 20.3.12.1. Overview
    • 20.3.12.2. Product Portfolio
    • 20.3.12.3. Sales Footprint
    • 20.3.12.4. Key Financials
    • 20.3.12.5. SWOT Analysis
    • 20.3.12.6. Strategy Overview
      • 20.3.12.6.1. Marketing Strategy
      • 20.3.12.6.2. Product Strategy
      • 20.3.12.6.3. Channel Strategy
  • 20.3.13. F. Hoffmann-La Roche Ltd.
    • 20.3.13.1. Overview
    • 20.3.13.2. Product Portfolio
    • 20.3.13.3. Sales Footprint
    • 20.3.13.4. Key Financials
    • 20.3.13.5. SWOT Analysis
    • 20.3.13.6. Strategy Overview
      • 20.3.13.6.1. Marketing Strategy
      • 20.3.13.6.2. Product Strategy
      • 20.3.13.6.3. Channel Strategy
  • 20.3.14. Fluidigm Corporation
    • 20.3.14.1. Overview
    • 20.3.14.2. Product Portfolio
    • 20.3.14.3. Sales Footprint
    • 20.3.14.4. Key Financials
    • 20.3.14.5. SWOT Analysis
    • 20.3.14.6. Strategy Overview
      • 20.3.14.6.1. Marketing Strategy
      • 20.3.14.6.2. Product Strategy
      • 20.3.14.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

관련자료